AI assistant
Sending…
STRATA Skin Sciences, Inc. — Director's Dealing 2021
Sep 9, 2021
35146_dirs_2021-09-09_db115862-6c3c-433e-a73e-da186a2bc56b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2021-09-07
Reporting Person: SHAMIR NACHUM (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-07 | SSKN Common Stock | P | 1155 | $1.4 | Acquired | 137527 | Direct |
| 2021-09-07 | SSKN Common Stock | P | 781 | $1.405 | Acquired | 138308 | Direct |
| 2021-09-07 | SSKN Common Stock | P | 9270 | $1.41 | Acquired | 147578 | Direct |
| 2021-09-07 | SSKN Common Stock | P | 9807 | $1.42 | Acquired | 157385 | Direct |
| 2021-09-07 | SSKN Common Stock | P | 50 | $1.425 | Acquired | 157435 | Direct |
| 2021-09-07 | SSKN Common Stock | P | 5112 | $1.43 | Acquired | 162547 | Direct |
| 2021-09-07 | SSKN Common Stock | P | 30 | $1.44 | Acquired | 162577 | Direct |
| 2021-09-07 | SSKN Common Stock | P | 407 | $1.45 | Acquired | 162984 | Direct |
| 2021-09-08 | SSKN Common Stock | P | 1542 | $1.45 | Acquired | 164526 | Direct |
| 2021-09-08 | SSKN Common Stock | P | 2382 | $1.46 | Acquired | 166908 | Direct |
| 2021-09-08 | SSKN Common Stock | P | 100 | $1.465 | Acquired | 167008 | Direct |
| 2021-09-08 | SSKN Common Stock | P | 21579 | $1.47 | Acquired | 188587 | Direct |
| 2021-09-08 | SSKN Common Stock | P | 10717 | $1.475 | Acquired | 199304 | Direct |
| 2021-09-08 | SSKN Common Stock | P | 8488 | $1.48 | Acquired | 207792 | Direct |
More from STRATA Skin Sciences, Inc.
Regulatory Filings
2026
Feb 11
Regulatory Filings
2025
Dec 17
Regulatory Filings
2025
Dec 10
Director's Dealing
2025
Nov 18
Interim / Quarterly Report
2025
Nov 14
Regulatory Filings
2025
Nov 13
Major Shareholding Notification
2025
Nov 7
Proxy Solicitation & Information Statement
2025
Oct 30
Regulatory Filings
2025
Oct 20
Regulatory Filings
2025
Oct 16